Molecular formula: | C24H29N5O3 |
Average mass: | 435.528 |
Monoisotopic mass: | 435.227040 |
ChemSpider ID: | 54833 |
1 of 1 defined stereocentres
Wikipedia
Spectra
(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}amino)butanoic acid
(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}amino)butanoic acid
(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}amino)butansäure
[German]
(S)-N-(1-Carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amine
137862-53-4
[RN]80M03YXJ7I
[UNII]Acide (2S)-3-méthyl-2-(pentanoyl{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}amino)butanoïque
[French]
L-Valine, N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
[ACD/Index Name]MFCD00865840
[MDL number]N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valin
[German]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-L-valine
[French]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valin
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}valin
[German]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}valine
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(2H-tétrazol-5-yl)-4-biphénylyl]méthyl}valine
[French]
[ACD/IUPAC Name]N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Valeryl-N-[2′-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine
Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
[ACD/Index Name](2S)-3-methyl-2-(N-{[2′-(1H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
(2S)-3-methyl-2-(N-{[2′-(2H-1,2,3,4-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
(2S)-3-Methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(2S)-3-Methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2S)-3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2S)-3-Methyl-2-{pentanoyl-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(S)-2-(N-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(S)-3-Methyl-2-{pentanoyl-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(S)-3-Methyl-2-{pentanoyl-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]amine
(S)-N-valeryl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-Valeryl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; Diovan; N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
1089736-73-1
[RN]1331908-02-1
[RN]3-Methyl-2-{((S)-pentanoyl)-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
7754038
[Beilstein]97%
[³H]valsartan
AGTR1_HUMAN
CGP 48933;Diovan;Tareg;CGP48933;CGP-48933
Diovan
[Wiki]DIOVAN HCT
Diovan®
EXFORGE
GPVI_HUMAN
Kalpress
L-Valine, N-(1-oxopentyl)-N-((2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)methyl)-
L-Valine,N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-3-yl]methyl]- (9CI)
L-Valsartan
Leukotriene B4 receptor 2
LT4R2_HUMAN
Miten
N-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine
N-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl}-L-valine
n-valeryl-n-[2-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-l-valine
Nisis
Platelet glycoprotein VI
Provas
Tareg
Type-1 angiotensin II receptor
Vals
Valsartan (Diovan)
Valsartan D9
valsartan labeled d9
valsartan, [3h]-
Valsartan-d3
valsatarn
Valtan
YV9455000 [RTECS]